Land: Malta
Språk: engelsk
Kilde: Medicines Authority
TRIMETHOPRIM, SULFAMETHOXAZOLE
Aspen Pharma Trading Limited 3016 Lake Drive City West Businees Campus Dublin 24, Ireland
J01EE01
TRIMETHOPRIM 40 mg/5ml SULFAMETHOXAZOLE 200 mg/5ml
ORAL SUSPENSION
TRIMETHOPRIM 40 mg/5ml SULFAMETHOXAZOLE 200 mg/5ml
POM
ANTIBACTERIALS FOR SYSTEMIC USE
Authorised
2006-04-17
1 PACKAGE LEAFLET 2 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT SEPTRIN PAEDIATRIC 40 MG/200 MG PER 5ML ORAL SUSPENSION TRIMETHOPRIM AND SULFAMETHOXAZOLE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOUR CHILD STARTS TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR THEM. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your child’s doctor or pharmacist. - This medicine has been prescribed for your child only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as your child. - If your child gets any side effects, talk to your child’s doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Septrin Paediatric Suspension is and what it is used for. 2. What you need to know before your child takes Septrin Paediatric Suspension. 3. How to give Septrin Paediatric Suspension. 4. Possible side effects. 5. How to store Septrin Paediatric Suspension. 6. Contents of the pack and other information. 1. WHAT SEPTRIN PAEDIATRIC SUSPENSION IS AND WHAT IT IS USED FOR Septrin Paediatric 40 mg/200 mg per 5 ml Oral Suspension (called ‘Septrin Paediatric Suspension’ in this leaflet) is a combination of two different antibiotics called sulfamethoxazole and trimethoprim, which is used to treat infections caused by bacteria. This medicine combination is also named as co-trimoxazole. Like all antibiotics, Septrin Paediatric Suspension only works against some types of bacteria. This means that it is only suitable for treating some types of infections. Septrin Paediatric Suspension can be used to treat or prevent: • lung infections (pneumonia) caused by the micro-organism, _Pneumocystis_ _jirovecii_ (previously known as _Pneumocystis carinii_ ) (some people call this ‘PJP’). Septrin Paediatric Suspension can be used to treat: • urinary bladder or urinary tract infections (water infections). • respiratory tract infections such as bronchitis. • read_full_document
Page 1 of 14 1. NAME OF THE MEDICINAL PRODUCT Septrin Paediatric 40 mg/200 mg per 5 ml Oral Suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 ml contains 40 mg Trimethoprim and 200 mg Sulfamethoxazole. Excipients with known effect: Contains 2.3 g of sorbitol (E 420) per 5 ml, 13.50 μL of ethanol per 5 ml, 5 mg of methyl hydroxybenzoate (E218) per 5 ml, 10.95 mg of sodium per 5 ml (inclusive of 5mg of sodium benzoate E 211), vanilla flavour with 0.00015 μL sulphur dioxide per 5 ml and 750 mg of glycerol per 5ml. For the full list of excipients, see section 6.1, 3. PHARMACEUTICAL FORM Oral suspension An off-white, banana and vanilla flavoured syrup. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Septrin Paediatric Suspension is indicated in infants and children aged 6 weeks to 12 years old ) for the treatment of the following infections when owing to sensitive organisms (see section 5.1) : _-_ _ _ _Urinary tract infections: _ For simple urinary tract infections, trimethoprim alone or another single antimicrobial agent is the preferred treatment. Since trimethoprim is also as efficacious as Septrin for the prophylaxis of recurrent urinary tract infections, Septrin is not indicated for prophylactic use. _-_ _ _ _Respiratory tract infections: _ Septrin may be used as second line therapy in chronic obstructive airways disease or other respiratory tract infections, including acute otitis media where sensitivity has been demonstrated or is highly probable. (Septrin is not indicated for prophylactic or prolonged administration in otitis media). _-_ _ _ Treatment and prevention of _Pneumocystis jirovecii pneumonitis (PJP)_ . _-_ _ _ Septrin may be used in the management of other serious conditions such as nocardiasis, toxoplasmosis and brucellosis. _ _ Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Treatment should be continued until the patient has been symptom free for two days; acute infections will read_full_document